Cytokinetics Presents New Data Related to Aficamten at the European Society of Cardiology Congress 2025
Additional Data from MAPLE-HCM Shows Aficamten Improves Cardiac Structure and Function Compared to…
SquaredFinancial unveils referral program with rewards up to $1,000 per client
VICTORIA, Seychelles, Aug. 18, 2025 /PRNewswire/ -- Technology-driven trading platform, SquaredFinancial, has launched…
Galapagos NV Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to GLPG5101 for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma
Mechelen, Belgium; August 6, 2025, 7:30 CET; regulated information – inside information…
Drger Receives Frost & Sullivan’s 2025 Global Company of the Year Recognition for Excellence in Respiratory Devices Innovation
Dräger recognized for pioneering innovations in respiratory care, delivering measurable improvements in…
ESHRE 41st Annual Meeting: Older paternal age linked to higher miscarriage risk and lower live birth rates in donor egg IVF cycles
A new international study presented today at the 41st Annual Meeting of…
KuCoin Futures Ranks 4th Globally on CoinGlass’ Latest Derivatives Exchange List
VICTORIA, Seychelles, July 3, 2025 /PRNewswire/ -- KuCoin, a leading global cryptocurrency…
CoinDesk Overnight Rates (CDOR) to Support Stablecoin Money Markets based on Aave
These first-of-kind money market rates transform Aave pool activity into conventional overnight…
Fibe Unveils Digital FDs, Strengthening Its Role as a One-Stop Financial Partner
Enables investments without a linked savings account, with options from top banks…
Manufacturers and Logistics Providers Embrace AI for Enhanced Barcode Reading Performance
Survey reveals 90% of users anticipate AI will improve accuracy, ease of…
Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New Phase 3 SOLARIS Data Showing No Incidence of PDSS with TE
Real-world claims studies evaluating UZEDY® (risperidone) also show improved adherence and persistence…